Related Experiment Videos
The activity and distribution of gamma-glutamyl transpeptidase (y-GT) in human foetal organs
Insights
Gamma-glutamyl transpeptidase (y-GT) activity varies in human fetuses. Enzyme levels increased in the kidney, pancreas, and thymus, while decreasing in the small intestine during development.
Area of Science:
- Biochemistry
- Developmental Biology
- Human Physiology
Background:
- Gamma-glutamyl transpeptidase (y-GT) is an enzyme with known roles in amino acid transport and detoxification.
- Understanding enzyme activity during human fetal development is crucial for identifying potential biomarkers and developmental pathways.
Purpose of the Study:
- To investigate the activity and distribution of y-GT in various human fetal organs.
- To analyze developmental trends of y-GT activity between 14 and 24 weeks of gestation.
- To explore potential correlations between fetal organ y-GT levels and human tumor enzyme activity.
Main Methods:
- Analysis of y-GT enzyme activity in post-mortem human fetal organ samples.
- Age range of fetuses: 14 to 24 weeks post-menstruationem.
- Organ samples included kidney, pancreas, thymus, small intestine, liver, lung, spleen, brain, and adrenals.
Main Results:
- y-GT activity showed a significant increase in the kidney, pancreas, and thymus over the studied gestational period.
- A decrease in y-GT activity was observed in the small intestine.
- High y-GT activity was noted in the liver without a clear trend; minimal to undetectable levels were found in the lung, spleen, brain, and adrenals.
Conclusions:
- Fetal organ development is characterized by dynamic changes in y-GT activity, with distinct patterns in different organs.
- The observed developmental changes in y-GT may have implications for understanding its role in fetal health and disease.
- Further research is warranted to elucidate the relationship between fetal y-GT levels and its activity in human tumors.
Abstract:
The activity and distribution of y-GT was investigated in a number of organs from human foetuses aged from 14 to 24 weeks post menstruationem. Over this period, enzyme activity increased in the kidney, pancreas and thymus, but decreased in the small intestine. No trend could be established for the liver, although activity was high. In the lung, spleen, brain and adrenals, y-GT was either detectable at very low levels or could not be demonstrated. The possible relationship between y-GT activity in some human tumours and the enzyme level in the corresponding foetal organs is discussed.